www.bms.com Open in urlscan Pro
45.60.154.161  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Our medicines Our science Our stories
Skip to main content
Contact us Careers
United States
Close Icon
Americas

Argentina

Spanish

Brazil

Portuguese

Canada

English French

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English
Asia Pacific

Australia

English

China

Simplified Chinese

India

English

Japan

Japanese

Korea

Korean

New Zealand

English

Singapore

English

Taiwan

Traditional Chinese

Thailand

English Thai
Europe

Austria

German

Belgium

English Dutch French

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

English Dutch

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

German French

United Kingdom

English
Middle East

Israel

Hebrew

Saudi Arabia

English Arabic

Turkey

Turkish

United Arab Emirates

English Arabic
Other

Other Markets

Distributor Markets

bmsUScqPageLucene

Medicines > Careers > Press Releases > Medical Information >


Previous Page Icon

Previous Page Icon

Patients & caregivers
Patients & caregivers
Our medicines
Survivorship Today
Patient resources
Get help paying for your medicines
Risk evaluation and mitigation strategies (REMS)
Plain language summaries of clinical trial results
Related links
Immunology patient resources
Our position on generic drugs
Our position on drug pricing
Psoriasis around the world

Healthcare providers
Healthcare providers
Learn about pre-approval access
Learn about post study drug access
340B practice fact sheet
Related links
U.S. medical information
Clinical trials

Researchers
Researchers
Areas of focus
In the pipeline
R&D expert voices
Our efforts in STEM
Clinical trials & research
Independent research
Related links
Research publications
Disclosure commitment
Areas of interest & research grants
Data sharing request process
Translational medicine

Investors
Investors
Stock information
Financial reporting
Analyst coverage
Events and presentations
Shareholder services
Investor contacts
Related links
Annual reports
Dividend history
Investment return calculator
SEC filings
Quarterly results

Business development
Business development
Our partnerships
Why partner with us
Areas of interest
Business development leadership team
Begin a discussion
Early innovation at BMS
Related links
Download business development brochure
Doing business with us as a supplier

News & media
News & media
Press releases
Our stories
Media library
Media contacts
Related links
Scientific media resources
Disease state infographics
Corporate resources

About us
About us
Our company
Leadership
Our science
Global Inclusion & Diversity
Our impact
Working at BMS
Contact us
Related links
Global Patient Week
Our technologies
Our history
Our locations
The Bristol Myers Squibb Foundation
Resource groups
Our positions





INVESTORS

Learn more about how we strive to produce sustained strong performance and
shareholder value.



NYSE : BMY

$58.41

Nov 13 - 4:00pm ET

-0.61 (-1.03%)

Change

11.213.940

Volume

59.21

Open

See Detailed Stock Info (20 MIN DELAY)


EXPLORE INVESTORS

 
Stock information
Financial reporting
Analyst coverage
Events and presentations
Shareholder services
Online delivery of shareholder materials
Investor contacts


--------------------------------------------------------------------------------


UPCOMING EVENTS VIEW ALL

There are currently no events scheduled.
nov 19, 2024 09:30 GMT
Jefferies London Healthcare Conference
 * Add
   Add to Calendar
    * Add to Apple Calendar
    * Add to Google Calendar
    * Add to Microsoft Outlook
    * Add to iCalendar

 * Webcast

feb 6, 2025 08:00 ET
Bristol Myers Squibb Q4 2024 Results Conference Call
 * Add
   Add to Calendar
    * Add to Apple Calendar
    * Add to Google Calendar
    * Add to Microsoft Outlook
    * Add to iCalendar

apr 24, 2025 08:00 ET
Bristol Myers Squibb Q1 2025 Results Conference Call
 * Add
   Add to Calendar
    * Add to Apple Calendar
    * Add to Google Calendar
    * Add to Microsoft Outlook
    * Add to iCalendar


RECENT EVENTS VIEW ALL

There are currently no events scheduled.
nov 11, 2024 
Guggenheim’s Inaugural Healthcare Innovation Conference
 * Webcast

ott 31, 2024 
Bristol Myers Squibb Q3 2024 Results Conference Call
 * Webcast
 * Press Release (PDF)
 * Quarterly Package of Financial Information (XLS)
 * Q3 2024 Results Presentation (PDF)
 * Q3 2024 Results Presentation (with Appendix) (PDF)
 * Preliminary Q3 2024 Acquired IPR&D and Licensing Income Schedule (PDF)

set 26, 2024 
Bristol Myers Squibb Cobenfy Approval
 * Press Release
 * Investor Overview

--------------------------------------------------------------------------------


OUR STORIES

View all

BIKING THE GLOBE
FOR C2C4C

DREAMING BIG AND TRUSTING IN TALENT: GETTING TO KNOW
JOHN LOVESETH

VOICES FROM R&D: PERSONAL EXPERIENCE INSPIRES THE DEVELOPMENT OF NEW MEDICINES

BIKING THE GLOBE
FOR C2C4C

DREAMING BIG AND TRUSTING IN TALENT: GETTING TO KNOW
JOHN LOVESETH

VOICES FROM R&D: PERSONAL EXPERIENCE INSPIRES THE DEVELOPMENT OF NEW MEDICINES




LATEST PRESS RELEASES VIEW MORE

Subscribe to Press Release Email Alerts >
11/11/2024
Bristol Myers Squibb Showcases the Continued Strength of its Cardiovascular
Portfolio with New Clinical and Real-World Data at American Heart Association
Scientific Sessions 2024
11/05/2024
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
10/31/2024
Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program
Evaluating COBENFY™ (xanomeline and trospium chloride) in Adults with
Schizophrenia at Psych Congress 2024
10/31/2024
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
10/28/2024
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes
Research Data at Psych Congress 2024


OUR REPORTS

ANNUAL REPORT

GLOBAL INCLUSION AND DIVERSITY REPORT

ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT



GLOBAL ACCESS REPORT

ANNUAL REPORT

GLOBAL INCLUSION AND DIVERSITY REPORT

ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT



GLOBAL ACCESS REPORT




OUR SCIENCE

We are guided by a single vision

TRANSFORMING PATIENTS' LIVES THROUGH SCIENCE

Our pipeline is focused on research in therapeutic areas where we believe we
have the best opportunity to deliver transformational medicines to patients.

Our R&D pipeline


INVESTOR RESOURCES



TOOL KIT


 * Buy shares
 * Check your account
 * Cost basis calculator
 * Investment return calculator
 * SEC filings


ANNUAL REPORTS



 * Interactive annual report
 * Annual report request
 * View past annual reports


NOTIFICATIONS & FAQS


 * Investor Statement on Eliquis Revenue Under IRA
 * Read FAQs for BMY shareholders
 * Read acquisition FAQs for Celgene shareholders
 * Read FAQs for Mirati shareholders
 * Abraxane CVR notification


EMAIL ALERTS


Click investor alerts to manage event, presentation and SEC Filing email
notifications, or select press release alerts to subscribe to company news
alerts.


 * Investor alerts
 * Press release alerts




BUSINESS DEVELOPMENT INFORMATION

BMS completes global license deal with SystImmune

 * Learn More

FAQs for Mirati shareholders

Frequently asked questions about Mirati

 * Learn More

FAQs for Celgene shareholders

Frequently asked questions about Celgene shares and CVRs.

 * Learn More

Tax information for Celgene shareholders

Information including IRS Form 8937.


 * Learn More




Materials on this website may contain information about the Company’s future
plans and prospects that constitute forward-looking statements for purposes of
the safe harbor provisions under the Private Securities Litigation Reform Act of
1995. Such forward-looking statements are based on current expectations and
involve inherent risks and uncertainties, including factors that could delay,
divert or change any of them, and could cause actual outcomes and results to
differ materially from current expectations. No forward-looking statement can be
guaranteed. Forward-looking statements contained on this website should be
evaluated together with the many uncertainties that affect Bristol Myers
Squibb's business, particularly those identified in the cautionary factors
discussion in the company’s most recent annual report on Form 10-K, quarterly
reports on Form 10-Q and current reports on Form 8-K. These documents are
available from the Securities and Exchange Commission, the Bristol Myers Squibb
website or from Bristol Myers Squibb Investor Relations.



In addition, any information contained on this website was current as of the
date presented and should not be relied upon as representing our estimates as of
any subsequent date. While we may elect to update forward-looking statements at
some point in the future, we specifically disclaim any obligation to do so, even
if our estimates change, whether as a result of new information, future events
or otherwise. Consequently, the company will not update the information
contained on the website and investors should not rely upon the information as
current or accurate after the presentation date. The website may also contain
certain non-GAAP financial measures, adjusted to exclude certain costs,
expenses, gains and losses and other specified items. Reconciliations of these
non-GAAP financial measures to the most comparable GAAP measures for a
particular quarterly period are available on the company’s website at
www.bms.com.





MAIN NAVIGATION

 * Sitemap
 * Home
 * Patients & caregivers
 * Healthcare providers
 * Researchers
 * Investors
 * News & media
 * About us


RESOURCES

 * Our medicines
 * Legal notice
 * Privacy notice
 * Your privacy choices
 * Trademarks
 * Forward-looking statement
 * UK-CA slavery and human trafficking statement (PDF)








FOLLOW US

 * 
 * 
 * 
 * 
 * 

 * Careers
 * Our stories
 * Contact us
 * Worldwide locations
 * 

September 26, 2024
© 2024 Bristol-Myers Squibb Company



Welcome! At Bristol Myers Squibb (BMS), we and our partners use cookies and
other technologies to improve your browsing experience, personalize content and
ads on this and other websites and for social media features. For further
information, please read ourGeneral Privacy Notice
Accept Cookies
Reject Cookies
Customize Cookie Preferences

Your Opt Out Preference Signal is Honored


 * YOUR PRIVACY


 * STRICTLY NECESSARY COOKIES


 * DO NOT SELL OR SHARE / OPT OUT OF TARGETED ADVERTISING


 * PERFORMANCE COOKIES

YOUR PRIVACY

We and our partners use cookies and other technologies (together "cookies") to
improve your browsing experience, personalize content and ads on this and other
websites and for social media features. To learn more about the different types
of cookies we use and your opt-out rights, see details under each tab. Note your
selections will only apply to the device and browser used to submit your
request. If you clear cookies on your browser, you will need to resubmit your
opt-out request.

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for our websites to function. We do not, therefore,
provide opt-out rights with respect to these cookies.

Cookies Details‎

DO NOT SELL OR SHARE / OPT OUT OF TARGETED ADVERTISING

Do Not Sell or Share / Opt Out of Targeted Advertising


Depending upon the state in which you reside, you may have the right to opt out
of targeted advertising, the sale of your personal information, and/or the
sharing of your personal information for cross-context behavioral advertising.
To submit your opt-out choices, click the "Do Not Sell or Share / Opt Out of
Targeted Advertising" toggle above to off.

 * TARGETING COOKIES
   
   Switch Label label
   
   These cookies may be set on your browser through our websites by our
   advertising partners and used to collect information about you on our
   websites and on other websites in order to show you ads that are more
   relevant to you.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies


These cookies allow us and our vendors to analyze, measure and improve the
performance of our websites, including to help us understand which pages are the
most and least popular and see how visitors move around the site.

Cookies Details‎
Back Button


COOKIE LIST

Filter Button
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Clear
checkbox label label
Apply Cancel
Confirm My Choices
Allow All